Status | Study |
Not yet recruiting |
Study Name: Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer Condition: Attenuated Familial Adenomatous Polyposis Familial Adenomatous Date: 2016-11-10 Interventions: Drug: Erlotinib Hydrochloride |
Recruiting |
Study Name: Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program Condition: Attenuated Familial Adenomatous Polyposis Deleterious Familial Date: 2016-04-14 Interventions: Other: Chart Review Database queried for the presence of c |